NCT02358018 68Ga-DOTATOC for Imaging of Neuroendocrine Tumors: Expanded Access Trial Status NO_LONGER_AVAILABLE Phase N/A
NCT02355535 Procaspase Activating Compound-1 (PAC-1) in the Treatment of Advanced Malignancies - Component 1 Status COMPLETED Phase PHASE1
NCT02348749 18F-MFBG Imaging for Evaluation of Neuroendocrine Malignancies Status COMPLETED Phase PHASE1/PHASE2
NCT02315625 Study of Mutation-Targeted Therapy With Sunitinib or Everolimus in People With Advanced Low- or Intermediate-Grade Neuroendocrine Tumors of the Gastrointestinal Tract and Pancreas With or Without Cytoreductive Surgery Status TERMINATED Phase PHASE2
NCT02299089 Phase II Study of Subcutaneous Inj. Depot of Octreotide in Patients With Acromegaly and Neuroendocrine Tumours (NETs) Status COMPLETED Phase PHASE2
NCT02279602 Rollover Protocol for Subjects Who Have Responded on Study 4218s - A Phase 2 Study Status COMPLETED Phase PHASE2
NCT02267967 Phase Ib/II Study of Sulfatinib in Treating Advanced Neuroendocrine Tumors Status COMPLETED Phase PHASE1
NCT02246322 A Clinical Trial With a New Needle Device Comparing Two Needles for EUS_FNA of Solid Lesions. Status UNKNOWN Phase NA
NCT02246127 Sequentiality of Everolimus and STZ-5FU in Advanced Pancreatic Neuroendocrine Tumor Status COMPLETED Phase PHASE3
NCT02174679 68Ga DOTATATE PET/CT in Neuroendocrine Tumors (Expanded Access) Status NO_LONGER_AVAILABLE Phase N/A
NCT02174549 Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer Status RECRUITING Phase PHASE1/PHASE2
NCT02134639 PET-CT Imaging of Neuro-endocrine Tumors and Preliminary Clinical Evaluation Status COMPLETED Phase N/A
NCT02132468 A Ph 2 Study of Fosbretabulin in Subjects w Pancreatic or Gastrointestinal Neuroendocrine Tumors w Elevated Biomarkers Status COMPLETED Phase PHASE2
NCT02067988 Holmium-166-radioembolization in NET After Lutetium-177-dotatate; an Efficacy Study Status COMPLETED Phase PHASE2
NCT01970540 Study Escalating Doses of PM01183 in Combination With Fixed Doxorubicin in Patients With Specific Advanced Unresectable Solid Tumors Status COMPLETED Phase PHASE1
NCT01967537 Evaluation of 68Gallium-DOTATATE PET/CT for Detecting Neuroendocrine Tumors Status COMPLETED Phase PHASE2
NCT01931488 124I-MIBG Tracer Evaluation of Myocardial Sympathetic Denervation and Assessment of Neuroendocrine Tumors. Status UNKNOWN Phase PHASE2